Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Vorinostat

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 12,882Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kyowa Kirin: New Data Analysis in cutaneous T-cell lymphoma Patients
    Kyowa Kirin: New Data Analysis in cutaneous T-cell lymphoma Patients

    10 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210610005352/en/Kyowa-Kirin-New-Data-Analysis-Shows-Link-between-Blood-Involvement-and-Response-to-Treatment-in-Cutaneous-T-cell-Lymphoma-CTCL-Patients

    BUSINESSWIRE
    10 Jun 2021
    Share Share
    Immetas Announces Series A Financing for Cancer and Inflammatory Disease
    Immetas Announces Series A Financing for Cancer and Inflammatory Disease

    23 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200923005183/en

    BUSINESSWIRE
    23 Sep 2020
    Share Share
    Five More Drugs get Local Clinical Trial Waiver for Importing, Marketing in India
    Five More Drugs get Local Clinical Trial Waiver for Importing, Marketing in India

    13 Jan 2015

    // Ramesh Shankar PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=86116&sid=1

    Ramesh Shankar PHARMABIZ
    13 Jan 2015
    Share Share